Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.
Herik Rodrigo AG, Tomonobu N, Yoneda H, Kinoshita R, Mitsui Y, Sadahira T, Terawaki SI, Gohara Y, Gede Yoni Komalasari NL, Jiang F, Murata H, Yamamoto KI, Futami J, Yamauchi A, Kuribayashi F, Inoue Y, Kondo E, Toyooka S, Nishibori M, Watanabe M, Nasu Y, Sakaguchi M.
Herik Rodrigo AG, et al. Among authors: jiang f.
Biochem Biophys Res Commun. 2022 Dec 17;634:83-91. doi: 10.1016/j.bbrc.2022.09.116. Epub 2022 Oct 6.
Biochem Biophys Res Commun. 2022.
PMID: 36240653
Free article.